MX386696B - Proceso para producir analogos de anillo de arilomicina - Google Patents
Proceso para producir analogos de anillo de arilomicinaInfo
- Publication number
- MX386696B MX386696B MX2019011517A MX2019011517A MX386696B MX 386696 B MX386696 B MX 386696B MX 2019011517 A MX2019011517 A MX 2019011517A MX 2019011517 A MX2019011517 A MX 2019011517A MX 386696 B MX386696 B MX 386696B
- Authority
- MX
- Mexico
- Prior art keywords
- sup
- arilomycin
- producing
- ring analogues
- ring
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
- C07D245/02—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Analytical Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Métodos para hacer un anillo de arilomicina de la fórmula t (ver fórmula) o sales o solvatos del mismo, en donde R, R1, R2, R3, R4, R5, R6, R7, R8, R9, R5, R10 y Pg1 son como se definen en la presente.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762477268P | 2017-03-27 | 2017-03-27 | |
| PCT/US2018/024351 WO2018183198A1 (en) | 2017-03-27 | 2018-03-26 | Process for making arylomyin ring analogs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2019011517A MX2019011517A (es) | 2019-11-18 |
| MX386696B true MX386696B (es) | 2025-03-19 |
Family
ID=61913697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019011517A MX386696B (es) | 2017-03-27 | 2018-03-26 | Proceso para producir analogos de anillo de arilomicina |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11192924B2 (es) |
| EP (1) | EP3601240B1 (es) |
| JP (1) | JP7041687B2 (es) |
| KR (1) | KR102589474B1 (es) |
| CN (2) | CN117777229A (es) |
| AU (2) | AU2018243724B2 (es) |
| ES (1) | ES2892173T3 (es) |
| HR (1) | HRP20211495T1 (es) |
| IL (1) | IL269532B (es) |
| MX (1) | MX386696B (es) |
| PL (1) | PL3601240T3 (es) |
| SG (1) | SG11201908932SA (es) |
| SI (1) | SI3601240T1 (es) |
| WO (1) | WO2018183198A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20180109858A (ko) | 2015-11-20 | 2018-10-08 | 알큐엑스 파마슈티컬스, 인크. | 마크로시클릭 광범위 항생제 |
| UA126027C2 (uk) * | 2017-02-15 | 2022-08-03 | АрКьюЕкс ФАРМАСЬЮТІКЛС, ІНК. | Макроциклічні антибіотики широкого спектра |
| IL288294B (en) * | 2019-05-28 | 2022-09-01 | Hoffmann La Roche | A broad-spectrum macrocyclic antibiotic |
-
2018
- 2018-03-26 MX MX2019011517A patent/MX386696B/es unknown
- 2018-03-26 AU AU2018243724A patent/AU2018243724B2/en active Active
- 2018-03-26 JP JP2019553110A patent/JP7041687B2/ja active Active
- 2018-03-26 CN CN202311833909.0A patent/CN117777229A/zh active Pending
- 2018-03-26 EP EP18716874.5A patent/EP3601240B1/en active Active
- 2018-03-26 WO PCT/US2018/024351 patent/WO2018183198A1/en not_active Ceased
- 2018-03-26 SI SI201830418T patent/SI3601240T1/sl unknown
- 2018-03-26 PL PL18716874T patent/PL3601240T3/pl unknown
- 2018-03-26 KR KR1020197031578A patent/KR102589474B1/ko active Active
- 2018-03-26 ES ES18716874T patent/ES2892173T3/es active Active
- 2018-03-26 HR HRP20211495TT patent/HRP20211495T1/hr unknown
- 2018-03-26 CN CN201880020965.3A patent/CN110475766B/zh active Active
- 2018-03-26 SG SG11201908932S patent/SG11201908932SA/en unknown
-
2019
- 2019-09-23 IL IL269532A patent/IL269532B/en unknown
- 2019-09-24 US US16/581,116 patent/US11192924B2/en active Active
-
2021
- 2021-11-02 US US17/517,103 patent/US11702452B2/en active Active
-
2022
- 2022-08-16 AU AU2022218486A patent/AU2022218486B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| SI3601240T1 (sl) | 2021-11-30 |
| CA3057997A1 (en) | 2018-10-04 |
| CN110475766A (zh) | 2019-11-19 |
| PL3601240T3 (pl) | 2021-12-20 |
| EP3601240A1 (en) | 2020-02-05 |
| IL269532A (en) | 2019-11-28 |
| US11192924B2 (en) | 2021-12-07 |
| AU2022218486A1 (en) | 2022-09-08 |
| BR112019020112A2 (pt) | 2020-05-05 |
| WO2018183198A1 (en) | 2018-10-04 |
| JP2020512353A (ja) | 2020-04-23 |
| US20220056078A1 (en) | 2022-02-24 |
| IL269532B (en) | 2021-12-01 |
| AU2018243724A1 (en) | 2019-10-03 |
| US11702452B2 (en) | 2023-07-18 |
| CN110475766B (zh) | 2023-12-29 |
| KR20190133033A (ko) | 2019-11-29 |
| ES2892173T3 (es) | 2022-02-02 |
| KR102589474B1 (ko) | 2023-10-16 |
| AU2018243724B2 (en) | 2022-07-28 |
| AU2022218486B2 (en) | 2023-09-28 |
| JP7041687B2 (ja) | 2022-03-24 |
| CN117777229A (zh) | 2024-03-29 |
| SG11201908932SA (en) | 2019-10-30 |
| US20200255476A1 (en) | 2020-08-13 |
| MX2019011517A (es) | 2019-11-18 |
| EP3601240B1 (en) | 2021-08-04 |
| HRP20211495T1 (hr) | 2021-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR132627A2 (es) | Procesos para preparar compuestos intermediarios de utilidad para sintetizar compuestos de carbamoilpiridona policíclicos | |
| MX394380B (es) | Compuestos dinucleótidos cíclicos para eltratamiento de cáncer | |
| EP4585268A3 (en) | Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same | |
| MX2021011683A (es) | Polimorfos de sepiapterina y sales de los mismos. | |
| MX2021012973A (es) | Sustituto de huevo y composiciones que comprenden el sustituto de huevo y metodos para producir el mismo. | |
| MX393879B (es) | Métodos de preparación de niraparib. | |
| MX383935B (es) | Amidas heterocíclicas como inhibidores de cinasa. | |
| PH12020550703A1 (en) | Sulfonamide compounds and use thereof | |
| MX2018006288A (es) | Inhibidores de acc tipo ester y usos de los mismos. | |
| UY36175A (es) | 3-amino-1,5,6,7-tetrahidro-4h-indol-4-onas | |
| CY1124450T1 (el) | Νουκλεοτιδια βητα-νικοτινικου εστερα και διεργασιες για την παρασκευη αυτων | |
| MX2020013630A (es) | Analogos de rapamicina y usos de los mismos. | |
| CO2017008600A2 (es) | Análogos de desacetoxitubulisina h, composiciones y método de producción de los mismos | |
| EA201791058A1 (ru) | Морфолин- и 1,4-оксазепан-амиды в качестве агонистов соматостатинового рецептора подтипа 4 (sstr4) | |
| MX378847B (es) | Nuevos derivados de gamma-amanitina | |
| BR112019020338A8 (pt) | Composição para produção de tagatose, e, método de produção de tagatose | |
| CL2019001804A1 (es) | Activador de nrf2. | |
| UA117779C2 (uk) | Піразини як модулятори gpr6 | |
| MY188420A (en) | Crystalline forms of (s)-afoxolaner | |
| CU24428B1 (es) | Derivados de quinolizinona como inhibidores de pi3k | |
| MX2020012990A (es) | Formulaciones de tegavivint y compuestos relacionados. | |
| MX2020004093A (es) | Puzolana de vidrio activada. | |
| CO2020006542A2 (es) | Profármacos de creatina, composiciones y métodos de uso de estos | |
| CL2021000663A1 (es) | Proceso para la producción de gas de síntesis. | |
| CY1120812T1 (el) | Υποκατεστημενα παραγωγα αζασπειρο(4.5)δεκανιου |